South Korea · Delayed Price · Currency is KRW IntoCell Statistics
Total Valuation
IntoCell has a market cap or net worth of KRW 274.30 billion. The enterprise value is 260.60 billion.
| Market Cap | 274.30B |
| Enterprise Value | 260.60B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
IntoCell has 15.02 million shares outstanding. The number of shares has increased by 11.31% in one year.
| Current Share Class | 15.02M |
| Shares Outstanding | 15.02M |
| Shares Change (YoY) | +11.31% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 21.89% |
| Owned by Institutions (%) | 9.45% |
| Float | 11.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 85.93 |
| PB Ratio | 13.95 |
| P/TBV Ratio | 18.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 81.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.85 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.98 |
| Interest Coverage | -31.37 |
Financial Efficiency
Return on equity (ROE) is -42.15% and return on invested capital (ROIC) is -17.09%.
| Return on Equity (ROE) | -42.15% |
| Return on Assets (ROA) | -13.76% |
| Return on Invested Capital (ROIC) | -17.09% |
| Return on Capital Employed (ROCE) | -38.83% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -42.86% |
| 50-Day Moving Average | 20,455.20 |
| 200-Day Moving Average | 39,720.80 |
| Relative Strength Index (RSI) | 39.63 |
| Average Volume (20 Days) | 48,968 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IntoCell had revenue of KRW 3.19 billion and -9.45 billion in losses. Loss per share was -632.13.
| Revenue | 3.19B |
| Gross Profit | 3.18B |
| Operating Income | -8.91B |
| Pretax Income | -9.45B |
| Net Income | -9.45B |
| EBITDA | -8.11B |
| EBIT | -8.91B |
| Loss Per Share | -632.13 |
Balance Sheet
The company has 23.93 billion in cash and 10.23 billion in debt, with a net cash position of 13.70 billion or 912.07 per share.
| Cash & Cash Equivalents | 23.93B |
| Total Debt | 10.23B |
| Net Cash | 13.70B |
| Net Cash Per Share | 912.07 |
| Equity (Book Value) | 19.66B |
| Book Value Per Share | 1,309.79 |
| Working Capital | 11.48B |
Cash Flow
In the last 12 months, operating cash flow was -10.18 billion and capital expenditures -213.96 million, giving a free cash flow of -10.40 billion.
| Operating Cash Flow | -10.18B |
| Capital Expenditures | -213.96M |
| Depreciation & Amortization | 800.19M |
| Net Borrowing | -38.92M |
| Free Cash Flow | -10.40B |
| FCF Per Share | -692.24 |
Margins
Gross margin is 99.73%, with operating and profit margins of -279.02% and -295.93%.
| Gross Margin | 99.73% |
| Operating Margin | -279.02% |
| Pretax Margin | -295.93% |
| Profit Margin | -295.93% |
| EBITDA Margin | -253.95% |
| EBIT Margin | -279.02% |
| FCF Margin | n/a |
Dividends & Yields
IntoCell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.31% |
| Shareholder Yield | -11.31% |
| Earnings Yield | -3.44% |
| FCF Yield | -3.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IntoCell has an Altman Z-Score of 18.21 and a Piotroski F-Score of 2.
| Altman Z-Score | 18.21 |
| Piotroski F-Score | 2 |